COVID Vaccine Preprint Study Prompts Twitter Outrage

News
890

Translate to Spanish or other 102 languages!

Image for illustration for Illustration purposes.

Medscape

- Advertisement -

A preprint study finding that the Pfizer-BioNTech mRNA COVID vaccine is associated with an increased risk for cardiac adverse events in teenage boys has elicited a firestorm on Twitter. 

Although some people issued thoughtful critiques, others lobbed insults against the authors, and still others accused them of either being anti-vaccine or stoking the fires of the vaccine skeptic movement.

For the complete story, click on the following link: https://www.medscape.com/viewarticle/958778?uac=209076CT&faf=1&sso=true&impID=3641968&src=mkm_covid_update_210915_MSCPEDIT

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
New FDA Records Show Purchases of Fetal Organs, Heads and Tissue for ‘Humanized Mice’ Project
Next article
Grand opening of HEAL Community Connection Center

More Articles

DHR Health To Add Advanced Vascular Care Services to Its Brownsville Multispecialty Clinic

Beginning August 31, 2026, patients living in the lower Rio Grande Valley, will have access to advanced vascular surgical services at the DHR Health Brownsville Multispecialty Clinic, located next to its hospital, DHR Health Brownsville, at 4770 N. Expressway.

CDC Issues Warning Over Multistate Salmonella Outbreak Linked to Jalapeños

The Centers for Disease Control and Prevention (CDC) has issued a food safety alert following a multistate outbreak of Salmonella infections linked to contaminated jalapeño peppers

ER 24/7 Brownsville – Grand Opening & Ribbon Cutting Ceremony, Aug. 6th

The Brownsville Chamber of Commerce and its Bienvenidos Committee are excited to announce the Grand Opening of ER 24/7 Brownsville today, August 6, 2026, at 3:00 PM. This celebration will take place at 449 E. Alton Gloor Blvd in Brownsville, Texas. 

New Blood Test Spots Early Signs of Immunotherapy Effectiveness

Researchers at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy determined that liquid biopsy—a blood test that detects circulating tumor DNA (ctDNA)—can predict, within a few weeks, whether patients with advanced non-small cell lung cancer are benefiting from immunotherapy.
- Advertisement -